Status of Cytomegalovirus Prevention and Treatment in 2000
Open Access
- 1 January 2000
- journal article
- Published by American Society of Hematology in Hematology-American Society Hematology Education Program
- Vol. 2000 (1) , 339-355
- https://doi.org/10.1182/asheducation-2000.1.339
Abstract
Cytomegalovirus (CMV) infection continues to be a problem in selected populations following hematopoietic stem cell transplantation (SCT). Although there have been no new antiviral agents for management of this infection in recent years, the methods for using the existing agents have improved with newer assays for detection of virus. In addition, our understanding of immunity to CMV has undergone considerable expansion. This paper will address these new aspects relating to CMV infection in the setting of SCT.Keywords
This publication has 0 references indexed in Scilit: